Resveratrol (RSV), a phytoalexin, has shown to prevent endothelial dysfunction and reduce diabetic vascular complications and the risk of cardiovascular diseases. The aim of this study was to investigate the signaling mechanisms underlying the protecting effects of RSV against endothelial dysfunction during hyperglycemia in vitro and in vivo. Human umbilical vein endothelial cells (HUVECs) were treated with RSV, and then exposed to high glucose (HG, 30 mmol/L). Akt-Ser473 phosphorylation, eNOS-Ser1177 phosphorylation, and PTEN protein levels in the cells were detected using Western blot. For in vivo studies, WT and Akt -/-mice were fed a normal diet containing RSV (400 mg·kg -1 ·d -1 ) for 2 weeks, then followed by injection of STZ to induce hyperglycemia (300 mg/dL). Endothelial function was evaluated using aortic rings by assessing ACh-induced vasorelaxation. RSV (5-20 μmol/L) dose-dependently increased Akt-Ser473 phosphorylation, accompanied by increased eNOS-Ser1177 phosphorylation in HUVECs; these effects were more prominent under HG stimulation. Transfection with Akt siRNA abolished RSV-enhanced eNOS phosphorylation and NO release. Furthermore, RSV (5-20 μmol/L) dose-dependently decreased the levels of PTEN, which was significantly increased under HG stimulation, and PTEN overexpression abolished RSV-stimulated Akt phosphorylation in HG-treated HUVECs. Moreover, RSV dramatically increased 26S proteasome activity, which induced degradation of PTEN. In in vivo studies, pretreatment with RSV significantly increased Akt and eNOS phosphorylation in aortic tissues and ACh-induced vasorelaxation, and improved diabetes-induced endothelial dysfunction in wild-type mice but not in Akt -/-mice. RSV attenuates endothelial function during hyperglycemia via activating proteasome-dependent degradation of PTEN, which increases Akt phosphorylation, and consequentially upregulation of eNOS-derived NO production.
Introduction
Diabetes mellitus is typically associated with the development of vascular complications, which are characterized by endothelial dysfunction [1] . Although the mechanisms of endothelial dysfunction are not fully understood, it is likely that hyperglycemia, the primary metabolic disturbance of diabetes mellitus, may initiate the defect [2, 3] . Loss of nitric oxide (NO) derived from endothelial NO synthase (eNOS) is essential for endothelial dysfunction, which is an early marker for cardiovascular diseases [4] . Thus, attenuating endothelial dysfunction by increasing NO release in diabetes is an effective approach.
Polyphenol resveratrol (RSV) is present in the skins of red grapes. RSV has attracted increasing scientific attention owing to its cardiovascular benefits and potent antitumor activity [5, 6] . In obese rodents, resveratrol treatment produces various health benefits, including enhanced vascular function, decreased restenosis and hypertension, reduced inflammation and a gene expression pattern resembling the gene expression pattern of caloric restriction [7] . Despite the significance of RSV for protecting against cardiovascular diseases, the mechanisms mediating these effects have remained uncharacterized.
Previous studies have shown that the phosphorylation of eNOS at serine 1177 plays an important role in the generation of NO in endothelial cells [8, 9] . Activation of eNOS upstream kinases, such as Akt and AMP-activated protein kinase, increase the phosphorylation of eNOS and improve endothelial function [10] . However, better understanding of the regulation of the eNOS upstream kinase responsible for endothelial dysfunction remains largely unknown. It remains to be reasonably established whether treatment with RSV via Akt increases eNOS-derived NO production in diabetes-induced
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Cell culture
Human umbilical vein endothelial cells (HUVECs) were obtained from Clonetics Inc (Walkersville, MD, USA) and cultured as describe previously [11] . HUVECs were grown in endothelial basal medium supplemented with 2% fetal bovine serum in a humidified atmosphere of 5% CO 2 +95% air at 37 °C.
Adenovirus infection of HUVECs
HUVECs were infected with adenovirus in medium with 2% fetal calf serum (FCS) overnight. The cells were then washed and incubated in fresh endothelium growth medium without FCS for an additional 12 h before experimentation.
Transfection of siRNA into cells Transient transfection of siRNA was performed according to Santa Cruz's protocol as described previously [12, 13] . The transfection medium was then replaced with normal medium, and cells were cultured for 48 h.
Western blot analysis
Cells and thawed mouse aortas were lysed in cold RIPA buffer. Protein concentrations were determined with a bicinchoninic acid protein assay system (Pierce, Rockford, IL, USA). Proteins were subjected to Western blots using ECL-Plus, as described previously [14] .
eNOS activity assay eNOS activity was monitored by L-
]arginine as described previously [11] . Briefly, protein samples were incubated in reaction buffer [ 
3 H]arginine (>66 Ci/mmol) per reaction] for 15 min at 37 °C and separated by Dowex-50W ion-exchange chromatography in 20 mmol/L HEPES (pH 5.5), 2 mmol/L EDTA, and 2 mmol/L EGTA. The flow-through was used for liquid scintillation counting.
Measurement of NO production
For NO detection, cells grown in 24-well plates were incubated for 30 min in the presence of 15 μmol/L DAF in PBS as described previously [15] . The intensity of DAF fluorescence was read by a microplate reader. NO serum levels were assayed by the Griess method as described previously [16] .
26S proteasome activity assay As described previously [17] , cleavage activity was monitored continuously by detection of free 7-amido-4-methylcoumarin with a fluorescence plate reader (Gemini, Molecular Devices, Sunnyvale, CA, USA) at 380/460 in total cell lysates by using the fluorogenic proteasome substrate Suc-LLVY-7-amido-4-methylcoumarin.
Reverse-transcription polymerase chain reaction for PTEN The levels of PTEN mRNA were assayed by using RT-PCR as described previously [16] . Constitutively expressed GADPH mRNA was amplified with forward (5'-ACCACAGTCCATGC-CATCACTGCC-3') and reverse (5'-ACCAGGAAATGAGCTT-GACAAAGT-3') primers in a similar manner for 26 cycles.
Measurement of tension development in aortic rings
The organ chamber study was performed as described previously [18, 19] . Aortic rings were suspended and mounted to an organ chamber using two stainless hooks. The rings were placed in organ baths filled with Kreb's buffer under a tension of 0.8 g for a 90-min equilibration period. After equilibration, the aortic rings were challenged with 60 mmol/L KCl. A contractile response was elicited by PE (1 μmol/L). At the plateau of contraction, accumulative ACh or SNP was added into the organ bath to induce vessel relaxation.
Statistical analysis
Statistical comparisons of vasodilation were performed using a two-way ANOVA. Intergroup differences were analyzed using Bonferroni's post-hoc test. Time-course studies were analyzed using a repeated measures ANOVA. All other results were analyzed by performing a one-way ANOVA. Values are expressed as the mean±SEM. P-values less than 0.05 were considered to be significant. Results RSV increases both Akt and eNOS phosphorylation in endothelial cells RSV activates Akt in many cells, such as liver cells, cancer cells, and neuron cells [20] . To investigate whether RSV also activates Akt in endothelial cells, we examined the dosedependent effects of RSV on Akt-Ser473 phosphorylation, which is essential for Akt activity. As shown in Figure 1A The important function of endothelial cell is to generate eNOS-derived NO to regulate vascular tone [16] . To investigate whether RSV activates eNOS, we measured eNOS phosphorylation at Ser1177, which represents active eNOS in endothelial cells treated with RSV. As shown in Figure 1B , treatment of HUVECs with RSV increased eNOS-Ser1177 phosphorylation in a dose-response fashion. These data suggest that RSV activates Akt and eNOS in endothelial cells.
RSV abolishes the reduction in Akt and eNOS phosphorylation induced by high glucose in endothelial cells
We next detected the effects of RSV in HUVECs under high glucose (HG) stimulation. As shown in Figure 1C and 1D, 
RSV-induced eNOS phosphorylation is Akt-dependent
Previous studies have demonstrated that Akt directly phosphorylates and activates eNOS in endothelial cells [21] . Given that RSV activates both Akt and eNOS in HUVECs, we then investigated whether the RSV-stimulated eNOS phosphorylation involves Akt in HUVECs by silencing Akt gene expression with specific siRNA transfection. As shown in Figure 2A , transfection of Akt siRNA but not control siRNA markedly abolished RSV-induced eNOS phosphorylation in HUVECs. Consistent with these results, siRNA-mediated knockdown of Akt abolished RSV-enhanced NO production and eNOS activity, whereas the control siRNA had no effect ( Figure 2B and  2C) . Collectively, these results suggest that Akt is required for RSV-stimulated eNOS phosphorylation and NO production in endothelial cells.
PTEN is essential for RSV-induced Akt phosphorylation
To understand how RSV activates Akt, we investigated whether RSV changes PTEN, a lipid phosphatase that dephosphorylates Akt [22] . As shown in Figure 3A , RSV reduced total PTEN protein levels in a dose-dependent manner. Importantly, RSV-induced Akt phosphorylation was blocked by overexpression of PTEN in cells infected with adenovirus containing PTEN cDNA but not the vector ( Figure 3B ). Furthermore, high glucose reduced the levels of eNOS and Akt phosphorylation, which was reversed by RSV. Similarly, the effects of RSV were also abolished by PTEN overexpression under high glucose conditions ( Figure 3C ). Taken together, these results imply that RSV-induced Akt phosphorylation requires PTEN.
The 26S proteasome mediates the RSV-induced reduction of PTEN in cells PTEN protein levels are controlled by 26S proteasomemediated degradation [23] . Thus, we investigated whether RSV via activation of the 26S proteasome increases PTEN protein degradation in HUVECs. As expected, RSV dramatically increased 26S proteasome activity in endothelial cells, whereas MG132, a proteasome inhibitor, inhibited 26S proteasome activity ( Figure 4A ). To determine the role of the 26S proteasome in RSV-reduced PTEN protein stability, we treated cells with MG132 in combination with RSV. As indicated in Figure 4B , co-administration of MG132 abolished RSV-induced reduction of PTEN protein. Both RSV and MG132 or the combination had no effects on PTEN mRNA levels ( Figure 4C ). Conversely, high glucose increased PTEN protein levels ( Figure 4D ). These data suggest that the alteration of PTEN levels is due to the activation of the 26S proteasome by RSV.
Administration of RSV prevents hyperglycemia-induced endothelial dysfunction in WT mice
We next determined the effects of RSV on endothelial dysfunction in vivo. The endothelial dysfunction model was established by STZ injection. As shown in Table 1 , administration of RSV did not alter blood glucose levels in either WT mice or Akt -/-mice with or without hyperglycemia. As indicated 
in Figure 5A , hyperglycemia dramatically decreased AChinduced endothelium-dependent vasorelaxation in WT mice, consistent with other reports [24] . Administration of RSV rescued hyperglycemia-induced impairments of endotheliumdependent relaxation. ACh-induced endothelium-dependent relaxation was inhibited by the eNOS inhibitor L-NAME (Figure 5B) , demonstrating that NO plays a major role in the beneficial effects of RSV. In addition, SNP-induced endotheliumindependent relaxation was not altered in all groups ( Figure  5C ), indicating that the effects of RSV are limited to the vascular endothelium but not smooth muscle.
Role of Akt in RSV-enhanced endothelium-dependent vaso relaxation Next, to investigate the role of Akt in endothelial function, we tested the effect of RSV in Akt -/-mice. As indicated in Figure improved by RSV compared with WT mice. Similarly, AChinduced endothelium-dependent relaxation was inhibited by the eNOS inhibitor L-NAME ( Figure 5E ). SNP-induced endo- thelium-independent relaxation was identical in each group of Akt -/-mice ( Figure 5F ). These data indicate that Akt plays an important role in enhanced endothelial function elicited by RSV.
RSV increases eNOS phosphorylation and NO production in vivo, which is Akt dependent Finally, we determined the effects of RSV on p-Akt, p-eNOS and NO production in vivo. As shown in Figure 6A , hyperglycemia dramatically increased the levels of PTEN protein. Furthermore, aortic levels of eNOS phosphorylation, Akt phosphorylation and serum levels of NO were significantly increased in RSV-treated WT but not Akt -/-mice with diabetes ( Figure 6B and 6C) . Overall, these results suggest that Akt is required for RSV-enhancement of the eNOS-NO pathway in vivo.
Discussion
In the present study, we provide evidence that RSV via PTENdependent Akt activation increases NO release and improves endothelial function in vivo. Furthermore, we demonstrate that activation of the proteasome mediates the protective effects of RSV in endothelial cells. These findings support a key role of the proteasome-PTEN-Akt-eNOS-NO pathway in the protective effects of RSV during hyperglycemia.
RSV is a parent compound of a family of molecules, including glucosides and polymers [25] , that exist in cis and trans configurations in a narrow range of spermatophytes of which vines, peanuts and pines are the prime representatives [26, 27] . RSV has been extensively studied and exhibits multiple pharmacological activities, such as antidiabetic, anti-inflammatory, neuroprotective, and antiproliferative activities, that combat against diabetes and cancer [28] [29] [30] [31] . Here, we further extended the novel functions of resveratrol in the improvement of endothelial functions during hyperglycemia. We also uncovered the molecular mechanism of resveratrol in the prevention of hyperglycemia-induced endothelial dysfunction, which is related to the PTEN-Akt-eNOS pathway and subsequent suppression of NO release. Resveratrol has been previously reported to produce cellular effects by regulating AMPK activity. Furthermore, AMPK activation elicits vasorelaxation in aortic arteries, and resveratrol effectively activates AMPK [13] . This finding supports the notion that AMPK activation may be involved in resveratrol-improved endothelial function. Furthermore, blood glucose was not altered by RSV treatment, suggesting that the beneficial effects of RSV are independent of blood glucose reduction, which is consistent with previous reports [32] . 
